Sanofi files Dupixent for severe asthma

2nd March 2018 Uncategorised 0

US regulators have accepted for review Sanofi/Regeneron’s biologic Dupixent as an add-on maintenance treatment in certain adults and adolescents with moderate-to-severe asthma.

More: Sanofi files Dupixent for severe asthma
Source: News